Related Experiment Video
Updated: Jan 2, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.2K
The role of cardiac rehabilitation using exercise to decrease natriuretic peptide levels in non-surgical patients: a
Christella S Alphonsus1,2, Pooveshni Govender3, Reitze N Rodseth4
11University of Cape Town, Cape Town, Western Cape South Africa.
Perioperative Medicine (London, England)
|December 14, 2019
Summary
Exercise therapy significantly reduces natriuretic peptide levels in patients, aiding in the prediction of cardiovascular outcomes. This intervention shows promise for improving patient prognosis, particularly within a 12-week timeframe.
Area of Science:
- Cardiology
- Exercise Physiology
Background:
- Exercise is recommended for cardiac failure patients and perioperative prehabilitation.
- Natriuretic peptides (NP) are key predictors of adverse postoperative cardiovascular outcomes.
Purpose of the Study:
- To determine if exercise therapy reduces natriuretic peptide levels.
- To identify the timeframe for NP reduction post-exercise.
- To assess if reduced NP levels correlate with decreased morbidity and mortality.
Main Methods:
- Meta-analysis of 16 trials.
- Searched databases: MEDLINE, CINAHL, EMBASE, ProQuest, Web of Science, Cochrane.
- Compared exercise intervention group with control group.
Main Results:
- Exercise therapy significantly reduced natriuretic peptide levels (SMD -0.45).
- Significant heterogeneity observed among trials.
- Reduction was evident within a 12-week period.
Conclusions:
- Exercise therapy is effective in lowering natriuretic peptide levels.
- Further research needed to confirm impact on morbidity and mortality.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
849
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
849
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
486
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
486
01:30Heart Failure V: Medical Management
176
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
176
01:22Heart Failure Drugs: Diuretics
751
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
751
01:28Mitral Regurgitation IV: Nursing Management
266
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
266
01:29Heart Failure II: Pathophysiology
615
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
615